[Cisternal therapy of encephalic and periencephalic diseases caused by central disorders; with a study on experimental psychiatry].
D002110:Caffeine / Q000627:therapeutic use*; D002493:Central Nervous System Diseases; D006801:Humans; D011343:Procaine / Q000627:therapeutic use*; D011570:Psychiatry
D002110:Caffeine; D011343:Procaine
CAFFEINE/therapeutic use; CENTRAL NERVOUS SYSTEM/diseases; PROCAINE/therapeutic use
Zysternale Therapie zentralbedingter Störungen des Nervensystems bei enzephalen und perienzephalen Erkrankungen, zugleich eine Studie zur experimentellen Psychiatrie.